Search Results for "Distributor Of Genway In India"

12:19 EDT 1st October 2014 | BioPortfolio

Original Source: GenWay Biotech, Inc

As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with solutions and applications for antibodies, recombinant proteins, full-length cDNAs, cell lines and tissue samples. We specialize in recombinant proteins and domain-specific IgY (chicken) antibodies and their applications. GenWay’s technology and expertise make high quality protein antigens that enable production of high quality antibodies. To date, ...

Matching Channels

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Matching News

Education on hygiene and sanitation is the need of the hour in India

Even after 66 years of independence, 60% of the rural population of India has no toilet facilities, although the figure is less than 9% in urban India.1 2 India launched the Nirmal Bharat Abhiyan... ...

Which doctors have been shortlisted for the BMJ Awards India 2014?

We received more than 500 high quality nominations for the first BMJ Awards India, showing medical excellence in diverse work throughout India.1 2 The BMJ team in India had the unenviable task of... ...

India’s generics industry hires consultant to boost image

Companies specializing in generic pharmaceuticals in India and the U.S. have retained India First Group to promote the benefits of affordable access to medicine as vital to improving healthcare worldw...

Judging the best of Indian healthcare

“We received an overwhelming number of nominations,” said Anand Ekambaram, managing director of BMJ India. More than 500 individuals and teams throughout India have been put forward.1“The BMJ In...

BIO Provides Recommendations for Growing India’s Biotech Industry

BIO and the Association of Biotechnology Led Enterprises (ABLE) released a new report today, entitled Accelerating Growth: Forging India’s Bioeconomy, which present recommendations in support the gr...

Murad Growth Plan Includes Distributor Acquisitions, New Retail Models

Doctor-founded skin-care firm acquires its U.K. distributor to strengthen its presence in prestige and professional channels while expanding its shop-within-a-shop model for “full expression of the ...

India Makes Clinical Research Comeback But Challenges Remain

Recent steps by the Indian government to streamline procedures for clinical trials are bringing a new glimmer of hope to the beleaguered industry. An improved framework now exists that puts India in a...

USIBC concludes successful pharmaceutical mission to India

The US-India Business Council (USIBC) has concluded its Pharmaceutical Executive Mission to Delhi, India. The delegation expressed its commitment to the Indian market, called for further dialogue with...

Matching PubMed Articles

Future and Training of Craniofacial Surgery in India.

Craniofacial surgery, in the strictest sense, is the surgery of structures above and behind the maxilla. Craniofacial surgery is not new to India and has been around for more than 4 decades now since ...

"I pick you": the impact of fairness and race on infants' selection of social partners.

By 15 months of age infants are sensitive to violations of fairness norms as assessed via their enhanced visual attention to unfair versus fair outcomes in violation-of-expectation paradigms. The curr...

Exploratory Qualitative Study for Community Management and Control of Tuberculosis in India.

Tuberculosis (TB) is a major public health problem in India which accounts for nearly one-fifth of the global TB burden. Though India has been gaining success in eliminating TB, the disease still kill...

Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India.

Cervical cancer is the leading cause of cancer mortality among women in India. Because Pap smear screening is not feasible in India, we need to develop effective alternatives.

Why are clinical trials necessary in India?

Clinical trials are emerging as an important activity in India as it is an essential component of the drug discovery and development program to which India is committed. The only robust way to evaluat...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement